These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 1709697

  • 1. Immediate-early gene expression is sufficient for induction of natural killer cell-mediated lysis of herpes simplex virus type 1-infected fibroblasts.
    Fitzgerald-Bocarsly P, Howell DM, Pettera L, Tehrani S, Lopez C.
    J Virol; 1991 Jun; 65(6):3151-60. PubMed ID: 1709697
    [Abstract] [Full Text] [Related]

  • 2. Positively selected Leu-11a (CD16+) cells require the presence of accessory cells or factors for the lysis of herpes simplex virus-infected fibroblasts but not herpes simplex virus-infected Raji.
    Fitzgerald-Bocarsly P, Feldman M, Curl S, Schnell J, Denny T.
    J Immunol; 1989 Aug 15; 143(4):1318-26. PubMed ID: 2526183
    [Abstract] [Full Text] [Related]

  • 3. Enhanced lysis of herpes simplex virus type 1-infected mouse cell lines by NC and NK effectors.
    Colmenares C, Lopez C.
    J Immunol; 1986 May 01; 136(9):3473-80. PubMed ID: 2420891
    [Abstract] [Full Text] [Related]

  • 4. Natural killer-mediated lysis of some but not all HSV-1- or VSV-infected targets requires the participation of HLA-DR-positive accessory cells.
    Howell DM, Fitzgerald-Bocarsly P.
    Immunology; 1991 Mar 01; 72(3):443-7. PubMed ID: 1851136
    [Abstract] [Full Text] [Related]

  • 5. Heterogeneity of human NK cells: comparison of effectors that lyse HSV-1-infected fibroblasts and K562 erythroleukemia targets.
    Fitzgerald PA, Evans R, Kirkpatrick D, Lopez C.
    J Immunol; 1983 Apr 01; 130(4):1663-7. PubMed ID: 6601135
    [Abstract] [Full Text] [Related]

  • 6. Human natural killer cell recognition of herpes simplex virus type 1 glycoproteins: specificity analysis with the use of monoclonal antibodies and antigenic variants.
    Bishop GA, Marlin SD, Schwartz SA, Glorioso JC.
    J Immunol; 1984 Oct 01; 133(4):2206-14. PubMed ID: 6206157
    [Abstract] [Full Text] [Related]

  • 7. Mechanism of recognition of herpes simplex virus type 1-infected cells by natural killer cells.
    López-Guerrero JA, Alarcón B, Fresno M.
    J Gen Virol; 1988 Nov 01; 69 ( Pt 11)():2859-68. PubMed ID: 2846762
    [Abstract] [Full Text] [Related]

  • 8. Herpes simplex virus-infected human fibroblasts are resistant to and inhibit cytotoxic T-lymphocyte activity.
    Posavad CM, Rosenthal KL.
    J Virol; 1992 Nov 01; 66(11):6264-72. PubMed ID: 1328666
    [Abstract] [Full Text] [Related]

  • 9. Role of interferon in natural kill of HSV-1-infected fibroblasts.
    Fitzgerald PA, von Wussow P, Lopez C.
    J Immunol; 1982 Aug 01; 129(2):819-23. PubMed ID: 6177785
    [Abstract] [Full Text] [Related]

  • 10. Role for major histocompatibility complex class I in regulating natural killer cell-mediated killing of virus-infected cells.
    Kaufman DS, Schoon RA, Leibson PJ.
    Proc Natl Acad Sci U S A; 1992 Sep 01; 89(17):8337-41. PubMed ID: 1325654
    [Abstract] [Full Text] [Related]

  • 11. Relationship between expression of herpes simplex virus glycoproteins and susceptibility of target cells to human natural killer activity.
    Bishop GA, Glorioso JC, Schwartz SA.
    J Exp Med; 1983 May 01; 157(5):1544-61. PubMed ID: 6189940
    [Abstract] [Full Text] [Related]

  • 12. Interferon-alpha-dependent and -independent participation of accessory cells in natural killer cell-mediated lysis of HSV-1-infected fibroblasts.
    Feldman M, Howell D, Fitzgerald-Bocarsly P.
    J Leukoc Biol; 1992 Nov 01; 52(5):473-82. PubMed ID: 1331279
    [Abstract] [Full Text] [Related]

  • 13. Natural killer cellular cytotoxicity against herpes simplex virus-infected cells in Igh-1-disparate mice.
    Tamesis RR, Foster CS.
    Invest Ophthalmol Vis Sci; 1990 Nov 01; 31(11):2224-9. PubMed ID: 1700771
    [Abstract] [Full Text] [Related]

  • 14. Lysis of herpes simplex virus-infected cells early in the infectious cycle by human antiviral antibody and complement.
    Cromeans TL, Shore SL.
    Infect Immun; 1981 Mar 01; 31(3):1054-61. PubMed ID: 6262246
    [Abstract] [Full Text] [Related]

  • 15. Lysis of herpes simplex virus (HSV) infected targets. IV. HSV-induced change in the effector population.
    Hendricks RL, Sugar J.
    Invest Ophthalmol Vis Sci; 1985 Feb 01; 26(2):208-13. PubMed ID: 3972502
    [Abstract] [Full Text] [Related]

  • 16. Natural killing of herpes simplex virus type 1-infected target cells: normal human responses and influence of antiviral antibody.
    Ching C, Lopez C.
    Infect Immun; 1979 Oct 01; 26(1):49-56. PubMed ID: 227799
    [Abstract] [Full Text] [Related]

  • 17. Herpes simplex virus glycoproteins: isolation of mutants resistant to immune cytolysis.
    Machtiger NA, Pancake BA, Eberle R, Courtney RJ, Tevethia SS, Schaffer PA.
    J Virol; 1980 May 01; 34(2):336-46. PubMed ID: 6246268
    [Abstract] [Full Text] [Related]

  • 18. Natural killer cell-mediated lysis of herpes simplex virus-infected fibroblasts: inability to detect soluble factors that contribute to lysis.
    Oh SH, Trinchieri G, Bandyopadhyay S, Starr SE.
    Cell Immunol; 1990 May 01; 127(2):221-9. PubMed ID: 2328528
    [Abstract] [Full Text] [Related]

  • 19. Enhancement of susceptibility of HSV-1-infected cells to natural killer lysis by interferon.
    Muñoz A, Carrasco L, Fresno M.
    J Immunol; 1983 Aug 01; 131(2):783-7. PubMed ID: 6190939
    [Abstract] [Full Text] [Related]

  • 20. Lysis of herpes simplex virus (HSV) infected targets. III. Effect of HSV on natural killer activity.
    Hendricks RL, Sugar J.
    Invest Ophthalmol Vis Sci; 1985 Feb 01; 26(2):201-7. PubMed ID: 2579040
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.